Senior Director, Commercial Strategy

Liquidia is deeply passionate and committed to the discovery, engineering, and development required to bring novel therapies to patients who need them most, and to the healthcare providers who care for them. Our current drive is toward improving the treatment of pulmonary hypertension (PH). We will continue to combine our proprietary, innovative PRINT® Technology with new and established medications, offering the potential for both better precision and improved clinical outcomes. Our team members include some of the industry’s top scientists, clinicians, business strategists, engineers, and pharmaceutical executives. We work together to help people lead longer, healthier, and happier lives.

Job Summary The Senior Director of Commercial Strategy leads new product planning and long‑range commercial strategy to drive future portfolio growth and strengthen brand positioning. This role integrates market insights, competitive intelligence, and product value strategy to inform early commercial assessments, shape clinical and development priorities, and guide strategic planning for pipeline assets as they progress toward commercialization. Education and Experience

• Bachelor’s degree required in Marketing, Business, Life Sciences, or a related field
• 10+ years of progressive experience in pharmaceutical or biotechnology commercial roles
• Significant experience in strategic marketing, commercial strategy, brand management, and/or new product planning
• Experience in rare disease, especially Pulmonary Hypertension, is a plus Knowledge, Skills, and Abilities
• Deep understanding of pharmaceutical commercialization, including brand strategy, lifecycle management, new product planning
• Strong understanding of clinical development processes, evidence-generation strategies, labeling considerations, and regulatory pathways.
• Analytical and insights capabilities—proficiency in interpreting qualitative and quantitative market research, competitive intelligence, and performance analytics
• Financial acumen—comfort with forecasting models, scenario planning, and business case development for lifecycle or pipeline investments
• Ability to thrive in small company environment
• Direct Commercial new product planning and lifecycle strategy. Provide input into future product development, specifically L606 BID Treprostinil. Integrate global market insights, financial opportunity, and portfolio strategy to optimize future commercial opportunity
• Shape upstream clinical development strategy for Phase III and IV studies. Translate unmet needs and financial value into endpoint/label discussions, patient population strategy, and evidence-generation plans to maximize future label strength and access potential
• Participate in the annual Brand Planning process for Yutrepia, establishing positioning, core messaging, and strategic objectives across HCP, patient, and payer stakeholders
• Track market intelligence for the PH landscape, monitoring market volume and share trends, competitor pipelines. Synthesize insights into decision-ready recommendations
• Perform market research to support brand planning, new product planning, and input into clinical development
• Act as the commercial voice on cross-functional product teams for programs in development. Integrate with Medical Affairs, Regulatory, Market Access, Commercial Analytics, Finance, and Business Development